We had cash and current marketable securities of $127,000,000 as of August 3, 2024, compared to $140,000,000 as of July 29, 2023. The $13,000,000 decrease in cash and current marketable securities over the trailing 12 months was driven primarily by share repurchases of $19,400,000 and capital expenditures of $14,700,000 offset by $23,600,000 in cash provided by operating activities. As of August 3, 2024, we have no debt on the balance sheet. During the Q2, we purchased approximately 945,000 shares of our common stock for $19,400,000 at an average price of $20.55 per share under the $25,000,000 repurchase authorization approved on June 5, 2024. 3rd quarter to date, we have purchased an additional 220,000 shares of our common stock for $5,600,000 or $25.39 per share, completing the June 5 authorization.